SULT2B1 and neoplasm: Moreover, it provided a solid experimental basis for future clinical applications of targeted drugs that inhibited tumour cell lipid metabolism to suppress distant metastasis, as well as the potential use of lovastatin to reduce distant metastasis in CC patients with high expression of SULT2B1.